logo
ACC Q1FY26 results: Net profit grows 4% amid increased sales volumes

ACC Q1FY26 results: Net profit grows 4% amid increased sales volumes

Cement major ACC's consolidated profit (attributable to the owners of the company) for the first quarter of the financial year 2026 (Q1 FY26) declined by 4.4 per cent year-on-year (YoY), to Rs 375.4 crore, amid a 12 per cent growth in sales volume.
The cement and clinker volume of Ambuja Cements' subsidiary stood at 11.5 million tonnes, the highest ever in the first quarter for the company. Meanwhile, trade sales volume grew by 6 per cent, and the share of premium products in trade sales stood at 41 per cent, up by 7 percentage points YoY. However, the profit missed the Bloomberg analysts' poll estimate of Rs 547 crore.
The company's revenue for the quarter grew by 17.3 per cent YoY, to Rs 6,098.1 crore, amid higher trade sales volume and a higher share of premium products in trade sales. The revenue comfortably surpassed the analysts' estimate of Rs 5,718.1 crore.
The company's total expenses for the quarter stood at Rs 5,594.25 crore, up 16.84 per cent YoY.
Vinod Bahety, whole-time director and chief executive officer, ACC, said, 'With a purpose-driven accelerated start to the year, our performance reflects the strength of our integrated strategy—anchored in premium sales, operational excellence, cost leadership, and a deep commitment to sustainability. The consistent growth in volumes, efficiency gains, and digital transformation initiatives are enabling us to deliver greater value to our customers and stakeholders.'
ACC's operating earnings before interest, taxes, depreciation, and amortisation (EBITDA) during Q1 FY26 stood at Rs 778 crore, up by 14.6 per cent. However, its operating EBITDA margin declined to 12.8 per cent in Q1 FY26 from 13.1 per cent in Q1 FY25.
Sequentially, the company's revenue declined marginally by 30 basis points, but the profit dipped by 50 per cent. These results come amid an all-India quarterly cement price hike of 6 per cent during the quarter, following a low base from Q1 FY25, which was affected by general elections. According to Elara Capital, the average pan-India cement prices rose by 3 per cent quarter-on-quarter (QoQ) in Q1 FY26 to Rs 377 per bag.
Cement demand growth in Q1 FY26 remained strong at 4 per cent, supported by favourable macroeconomic conditions and sustained demand from the housing and infrastructure sectors, the company noted.
During Q1 FY26, the company's kiln fuel cost reduced by 10 per cent, thanks to the use of low-cost imported petcoke, improved linkage and captive coal consumption, and synergies with group companies. The company's logistics costs also reduced by 5 per cent to Rs 972 per tonne.
"Healthy upticks in volumes, operational efficiency, cost control, and capex management affirm our progress and reinforce our commitment to industry-leading cost competitiveness," the company stated.
During the quarter under review, ACC's net worth increased by Rs 228 crore to Rs 18,787 crore as of June 30, 2025.
The outlook for Q2 FY26 remains strong. For FY26, cement demand is expected to grow between 6 and 7 per cent due to a rise in demand for affordable housing (both rural and urban) and higher spending on infrastructure and the commercial sector, which includes increased investment in the core and allied infrastructure sectors, ACC noted.
Additionally, ACC's shares listed on the Bombay Stock Exchange closed at Rs 1,893.40 per equity share on Thursday (24 July).
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

European shares rise as investors buy dips, shrug off US threats
European shares rise as investors buy dips, shrug off US threats

Deccan Herald

time12 minutes ago

  • Deccan Herald

European shares rise as investors buy dips, shrug off US threats

European shares extended gains on Wednesday as investors bought into recent market weakness, brushing aside fresh U.S. tariff threats and digesting a mixed batch of corporate earnings. The pan-European STOXX 600 index was up 0.3%, as of 0713 GMT, rising for a third consecutive session after touching a five-week low on Friday. Germany's blue-chip DAX and France's CAC 40 climbed 0.5% and 0.4%, respectively. Shares of Commerzbank rose nearly 1% after the German lender posted its quarterly net profit above expectations and raised parts of its full-year outlook. Siemens Energy said it expects to hit the upper end of its 2025 growth outlook estimates. Shares rose 1.2%. Swiss President Karin Keller-Sutter was set to meet U.S. Secretary of State Marco Rubio as Switzerland seeks to negotiate the 39% tariff scheduled to take effect on Thursday. Switzerland's benchmark SMI index edged 0.1% lower. European healthcare stocks slipped 0.7%, weighed down by a 1.3% drop in heavyweight Novo Nordisk after the Danish drugmaker maintained its full-year outlook, just days after slashing its 2025 sales outlook. The Wegovy maker said it would cut costs after losing nearly $95 billion in market value last week.

Narayana Health to add 2,000 beds, expand insurance schemes in FY26
Narayana Health to add 2,000 beds, expand insurance schemes in FY26

Business Standard

time18 minutes ago

  • Business Standard

Narayana Health to add 2,000 beds, expand insurance schemes in FY26

Bengaluru-headquartered hospital chain Narayana Health aims to grow its domestic revenue by 10 per cent in FY26, in line with industry benchmarks, a senior company official said. Managing director and chief executive officer Emmanuel Rupert told Business Standard: 'Last fiscal we did about Rs 4,349 crore in India revenue and we want to grow at a rate at which the healthcare industry is growing — over 10 per cent. We look to be on the same momentum and revenue.' Sandhya J, chief financial officer at Devi Shetty's Narayana Health, said the company plans to scale up its Aditi and Arya health insurance schemes in Karnataka and West Bengal. 'The entire healthcare ecosystem is failing in trust. We are on the path to solve the trust deficit and episodic interference of fund transfer. On the back of this, we aim to double down on our insurance scheme and build a strong customer base in Bengaluru, Shivamogga, Mysore, and Kolkata.' Commenting on efforts to improve profit after tax (PAT), which declined 2.3 per cent to Rs 196 crore in Q1 due to increased investments in integrated care and other financial costs, Sandhya said PAT optimisation will improve as the India business grows. Some clinics have started breaking even, reducing losses from the health insurance schemes. 'Over a period of time, we will be able to keep the losses in check and expand margins in the domestic business. PAT should improve. Finance cost will continue to increase due to the Rs 3,000 crore project to add 2,000 beds across India over the next three years. The integrated care dilution will continue over the next year but we hope to maintain a decent level of cash burn.' She added that a large part of the funding will come through bank borrowings and non-convertible debentures (NCDs) as needed. So far, Rs 800 crore has been raised for projects already signed. The CFO noted that about Rs 1,500–2,000 crore in loans might be raised in this fiscal, depending on upcoming project developments. 'We are exploring opportunities to expand, some might be inorganic as well. Borrowings will be linked to the construction progress of our current projects.' During the quarter, revenue from international patients declined, primarily due to reduced footfall from Bangladesh. Narayana expects this trend to continue, given ongoing geopolitical tensions. 'The goal is to keep focusing on domestic growth and see how well we can push the numbers. Eventually, in the next two to three years, we believe that revenue contribution from Bangladesh will go down to zero. Not to miss, the country is building its own healthcare infrastructure.' Looking ahead, Narayana expects its integrated care business to account for a larger share of overall revenue. At present, cardiac sciences and oncology contribute approximately 33 per cent and 16 per cent, respectively. On Tuesday, the Clinical Research team and Medha AI developed an artificial intelligence (AI) model that predicts left ventricular ejection fraction from ECG images, enabling early heart failure detection and improved diagnostic access. 'All along we have waited for Western countries to develop these technologies. Today we are developing this because this country is blessed with phenomenally skilled, passionate software engineers and AI experts. This is our strength. We have made massive investments in building the digital platform, which is far ahead of all the other hospitals. With the great combination of a digital platform and the AI tool, healthcare will never be the same,' said Devi Prasad Shetty, chairman and founder of Narayana Health, at a media briefing. The company said that trained on over 100,000 ECG images paired with echocardiogram reports, the model showed strong predictive performance. With external validation across 14 tertiary centres and over 57,000 patients, it identified 97 per cent of individuals with severely reduced ejection fraction (≤35 per cent).

Goa govt absorbed expenditure of Rs 65cr under zero water bill scheme
Goa govt absorbed expenditure of Rs 65cr under zero water bill scheme

Time of India

time21 minutes ago

  • Time of India

Goa govt absorbed expenditure of Rs 65cr under zero water bill scheme

Porvorim: During the period for which the PWD implemented the Zero Water Bill Scheme, from Sep 1, 2021, to April 30, 2025, it issued 41.9 lakh zero bills to domestic consumers. The total bill amount of Rs 65.5 crore was waived under the scheme, stated the reply tabled in the assembly by chief minister Pramod Sawant to a question by Velim MLA Cruz Silva. Goa govt officially ended its zero-bill scheme on May 1. The scheme allowed the drinking water bill to be waived for families who limited their usage to less than 16,000 litres of water per month. The idea behind the scheme was to encourage the judicious use of drinking water resources. However, the CM said that earlier this year, the scheme of free water to consumers had to be stopped due to the misuse of water to wash cars or sustain gardens. He said govt is already supplying treated water to consumers by bearing a loss of Rs 16 per litre. Sawant said that the total water demand for domestic, commercial, and industrial uses is 695MLD — with system losses being factored in. The CM told the House that the highest demand for water at 146.5MLD is in Salcete taluka, followed by 123MLD in Bardez, and 94MLD in Tiswadi. He, however, said that no village of Goa faces an acute water shortage. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Jennifer Garner's sweet photo on sprawling family farm gets fans talking Watch More Undo 'The complaints regarding water shortages or non-supply of water are of a localised nature due to power failure, leakages, breakdowns, and the blockage of pipelines,' he said. The CM said these problems are attended to within the shortest possible time. 'In such eventualities, tanker supply is resorted to as a short-term measure. However, as a long-term measure, govt is investing in upgrading and modernising water treatment facilities, distribution networks, and storage systems,' he said. Sawant stated that 11 projects for new water treatment plants or augmentation of the capacity of existing plants are under process. He said that three plants — at Ganjem, Tuem, and Siolim — will be commissioned in Dec 2025.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store